GRIMES & Co WEALTH MANAGEMENT, LLC Q2 2023 Filing

Filed July 19, 2023

Portfolio Value

$2.8T

Holdings

315

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (315 positions)

#	Stock	Shares	Value	% Portfolio	Type
301	—MERSANA THERAPEUTICS INC	15,740	$51.8M	0.00%
302	VORVOR BIOPHARMA INC	13,622	$42.1M	0.00%
303	ASNSUSDX4 PHARMACEUTICALS INC	15,000	$29.1M	0.00%
304	PSN 0.25 08/15/25PARSONS CORP DEL	25,000	$28.6M	0.00%
305	RBBNRIBBON COMMUNICATIONS INC	10,030	$28.0M	0.00%
306	IBRXIMMUNITYBIO INC	10,000	$27.8M	0.00%
307	VSH 2.25 06/15/25VISHAY INTERTECHNOLOGY INC	20,000	$21.9M	0.00%
308	FUBOFUBOTV INC	10,000	$20.8M	0.00%
309	—APOLLO COML REAL ESTATE FIN	20,000	$19.8M	0.00%
310	AYX 0.5 08/01/24ALTERYX INC	20,000	$18.8M	0.00%
311	ONSGBPOUTLOOK THERAPEUTICS INC	10,000	$17.4M	0.00%
312	RGLSREGULUS THERAPEUTICS INC	10,363	$15.2M	0.00%
313	ARCC 4.625 03/01/24ARES CAPITAL CORP	15,000	$15.0M	0.00%
314	VIAV 1 03/01/24VIAVI SOLUTIONS INC	10,000	$9.9M	0.00%
315	GWRE 1.25 03/15/25GUIDEWIRE SOFTWARE INC	10,000	$9.6M	0.00%

PreviousPage 4 of 4